Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | RO-05-2921 | HCID 76175 | — |
| Reactant | 2-Bromo-N-isopropyl-N-(4-methoxyphenyl)acetamide | HCID 10779534 | — |
| Product | HCID 19063673 | HCID 19063673 | — |
Reaction Steps
By employing conditions similar to those described in Intermediate 11, 5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one (Bock et. al., J. Org. Chem. 1987, 52, 3232-3239. 3.00 g, 12.71 mmol) and 2-bromo-N-isopropyl-N-(4-methoxy-phenyl)-acetamide (3.820 g, 13.35 mmol) are converted to the title compound, which is obtained as a wet white solid. The product is dissolved in anhydrous DCM, dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue is triturated with n-hexane, filtered and dried overnight under vacuum to provide the title compound as a white solid (5.380 g, 12.18 mmol). 1H NMR (300 MHz, d6-DMSO) δ=0.91-0.97 (m, 6H); 3.70 (d, J=10.4 Hz, 1H); 3.76 (s, 3H); 4.08 (s, 2H); 4.51 (d, J=10.6 Hz, 1H); 4.67-6.78 (m, 1H); 6.97-7.63 (m, 13H). MS (FAB): [M+H]+ =442.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05795887 |
|---|
| Source dataset | uspto-grants-1998_08 |
|---|
| ORD ID | ord-f0a92f0397ed4f26b1c4450579633c3f |
|---|
| Source note | uspto-grants-1998_08 |
|---|